Wolverine Trading’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $369K | Buy |
143,600
+22,200
| +18% | +$57.2K | ﹤0.01% | 4072 |
|
|
2025
Q2 | $328K | Buy |
121,400
+32,400
| +36% | +$87.1K | ﹤0.01% | 3386 |
|
|
2025
Q1 | $279K | Sell |
89,000
-6,300
| -7% | -$19.1K | ﹤0.01% | 3600 |
|
|
2024
Q4 | $255K | Buy |
95,300
+23,700
| +33% | +$98.7K | ﹤0.01% | 4214 |
|
|
2024
Q3 | $281K | Buy |
+71,600
| New | +$331K | ﹤0.01% | 3700 |
|
|
2024
Q2 | – | Sell |
-44,700
| Closed | -$240K | – | 4813 |
|
|
2024
Q1 | $240K | Buy |
44,700
+19,000
| +74% | +$86K | ﹤0.01% | 3594 |
|
|
2023
Q4 | $129K | Buy |
25,700
+1,700
| +7% | +$5.33K | ﹤0.01% | 4037 |
|
|
2023
Q3 | $40.6K | Sell |
24,000
-10,400
| -30% | -$20.9K | ﹤0.01% | 4223 |
|
|
2023
Q2 | $93.6K | Sell |
34,400
-11,100
| -24% | -$31.4K | ﹤0.01% | 3794 |
|
|
2023
Q1 | $80K | Sell |
45,500
-31,500
| -41% | -$97.9K | ﹤0.01% | 3719 |
|
|
2022
Q4 | $390K | Sell |
77,000
-10,900
| -12% | -$59.9K | ﹤0.01% | 2548 |
|
|
2022
Q3 | $434K | Buy |
87,900
+64,600
| +277% | +$294K | ﹤0.01% | 2765 |
|
|
2022
Q2 | $88K | Sell |
23,300
-9,700
| -29% | -$39K | ﹤0.01% | 3884 |
|
|
2022
Q1 | $194K | Buy |
33,000
+1,100
| +3% | +$6.75K | ﹤0.01% | 4454 |
|
|
2021
Q4 | $204K | Buy |
+31,900
| New | +$240K | ﹤0.01% | 4683 |
|
|
2021
Q3 | – | Sell |
-26,200
| Closed | -$381K | – | 6548 |
|
|
2021
Q2 | $381K | Sell |
26,200
-2,700
| -9% | -$44.6K | ﹤0.01% | 4087 |
|
|
2021
Q1 | $686K | Buy |
28,900
+4,500
| +18% | +$117K | ﹤0.01% | 3259 |
|
|
2020
Q4 | $350K | Sell |
24,400
-29,900
| -55% | -$288K | ﹤0.01% | 3571 |
|
|
2020
Q3 | $390K | Buy |
+54,300
| New | +$541K | ﹤0.01% | 3080 |
|
|
2020
Q2 | – | Sell |
-26,900
| Closed | -$84K | – | 4853 |
|
|
2020
Q1 | $84K | Buy |
+26,900
| New | +$135K | ﹤0.01% | 4090 |
|
Other funds holding IBRX
HCM
WP
AC
